NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-276-2011-0-JP-06 Compounds And Methods For The Prevention And Treatment Of Tumor Metastasis And Tumorigenesis JP National Stage 547550/2014 Issued
NIAID E-240-2012-1-US-02 CD-4 Mimetic Inhibitors Of HIV Entry And Methods Of Use Thereof US National Stage 14/365,389 9403763 Issued PDF
NICHD E-302-2011-0-US-06 Identification Of Two Novel Biomarkers For Niemann-Pick Disease Type C US National Stage 14/365,398 Abandoned
NCI E-117-2011-0-HK-10 Recombinant Immunotoxin Targeting Mesothelin HK National Stage 14105586.3 Abandoned
NIDCR E-160-2014-0-US-01 Detection Of Hepatitis Delta Virus (HDV) For Diagnosis And Treatment Of Lymphoma US 62/011,962 Abandoned
NCATS E-276-2011-0-US-07 Compounds and Methods for the Prevention and Treatment of Tumor Metastasis and Tumorigenesis US National Stage 14/364,759 9663521 Issued PDF
NCI E-025-2009-0-IL-21 Ratio Based Biomarkers And Methods of Use Thereof IL DIV 233098 Issued
NCI E-025-2009-0-IL-20 Ratio Based Biomarkers And Methods of Use Thereof IL DIV 233097 Issued
NCI E-025-2009-0-IL-18 Ratio Based Biomarkers And Methods of Use Thereof IL DIV 233095 Issued
NCI E-025-2009-0-IL-19 Ratio Based Biomarkers And Methods of Use Thereof IL DIV 233096 Issued
NCI E-057-2013-0-PCT-02 Method For Treating Tumors PCT PCT PCT/US2014/042117 Expired
NIDDK E-161-2014-0-US-01 Heterocyclic Compounds and Methods of Use Thereof US 62/011,462 Abandoned
NIDCR E-194-2010-0-US-02 Epidermal Growth Factor Receptor (EGFR) and Methods of Use in Adenoviral-Associated Virus Type 6 (AAV6) Transduction US ORD 14/301,973 9439979 Issued PDF
NIDCR E-018-2009-1-US-07 Differentially Expressed MicroRNAs As Biomarkers For The Diagnosis And Treatment of Sjogrens Syndrome US CON 14/301,602 Abandoned
NCI E-351-2013-0-PCT-02 HER2-SPECIFIC MONOCLONAL ANTIBODIES AND CONJUGATES THEREOF PCT PCT PCT/US2014/041492 Expired
NCI E-042-2009-0-US-08 Immunogenic Epitopes of NGEP Antigen US CON 14/299,763 Abandoned
NCI E-058-2015-1-EP-06 MATERIALS AND METHODS RELATED TO NSAID CHEMOPREVENTION IN COLORECTAL CANCER EP National Stage 12853542.4 Abandoned
NCI E-011-1998-0-US-07 Mammalian Selenoprotein Differentially Expressed in Tumor Cells US CON 14/300,143 Abandoned
NCI E-215-2014-7-US-01 COMBINATION THERAPIES TARGETING TUMOR-ASSOCIATED STROMA OR TUMOR CELLS US 62/009,425 Abandoned
NCI E-215-2014-6-US-01 COMBINATION THERAPIES TARGETING TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND TOPOISOMERASE US 62/009,421 Abandoned
NCI E-215-2014-5-US-01 COMBINATION THERAPIES TARGETING TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND MICROTUBULES US 62/009,417 Abandoned
NCI E-215-2014-4-US-01 COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR ASSOCIATED STROMA OR TUMOR CELLS US 62/009,414 Abandoned
NCI E-215-2014-3-US-01 COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR ASSOCIATED STROMA OR TUMOR CELLS US 62/009,380 Abandoned
NCI E-215-2014-2-US-01 COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR ASSOCIATED STROMA OR TUMOR CELLS AND ALKYLATING AGENTS US 62/009,376 Abandoned
NCI E-215-2014-1-US-01 COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR ASSOCIATED STROMA OR TUMOR CELLS AND OTHER PATHWAYS US 62/009,371 Abandoned
NCI E-215-2014-0-US-01 COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND TUMOR VASCULATURE US 62/009,369 Abandoned
NIAID E-051-2012-3-US-06 Broadly Neutralizing HIV-1 VRC07 Antibodies that Bind to the CD4-Binding Site of the Envelope Protein US National Stage 14/363,740 9695230 Issued PDF
NCI E-099-2014-0-US-01 Mesothelin-Targeted Chimeric Antigen Receptors and Uses Thereof US 62/008,851 Abandoned
NCI E-034-2013-0-CA-03 Monomeric Griffithsin Tandemers CA National Stage 2914498 Issued
NCI E-034-2013-0-GB-10 Monomeric Griffithsin Tandemers GB EP 14736527.4 Issued
NCI E-034-2013-0-EP-06 Monomeric Griffithsin Tandemers EP National Stage 14736527.4 Issued
NCI E-034-2013-0-FR-09 Monomeric Griffithsin Tandemers FR EP 14736527.4 Issued
NCI E-034-2013-0-DE-08 Monomeric Griffithsin Tandemers DE EP 14736527.4 Issued
NCI E-034-2013-0-AU-05 Monomeric Griffithsin Tandemers AU National Stage 2014274927 Issued
NCI E-034-2013-0-PCT-02 Monomeric Griffithsin Tandemers PCT PCT PCT/US2014/040992 Expired
NIAID E-281-2006-0-US-04 Rnase A Peptides, Fragments and Uses Thereof US CON 14/297,078 Abandoned
NHLBI E-115-2013-0-FR-07 Encircling Implant Delivery System And Methods FR EP 14735030.0 Issued
NHLBI E-115-2013-0-DE-06 Encircling Implant Delivery System And Methods DE EP 14735030.0 Issued
NHLBI E-115-2013-0-IE-09 Encircling Implant Delivery System And Methods IE EP 14735030.0 Issued
NHLBI E-115-2013-0-EP-03 Encircling Implant Delivery System And Methods EP National Stage 14735030.0 Issued
NHLBI E-115-2013-0-CH-05 Encircling Implant Delivery System And Methods CH EP 14735030.0 Issued
NHLBI E-115-2013-0-GB-08 Encircling Implant Delivery System And Methods GB EP 14735030.0 Issued
NHLBI E-115-2013-0-PCT-02 Encircling Implant Delivery System And Methods PCT PCT PCT/US2014/040716 Expired
NCATS E-234-2012-0-EA-11 PAK Inhibitors For the Treatment of Fragile X Syndrome EA National Stage 201490925 Pending
NINDS E-043-2012-0-US-03 SuBLIME: Automatic Brain Lesion Incidence And Detection Using Multimodality Longitudinal Magnetic Resonance Imaging US National Stage 14/362,354 9607392 Issued PDF
NICHD E-274-2000-0-US-05 Vibrio Cholerae 0139 Conjugate Vaccines US DIV 14/293,745 9173932 Abandoned PDF
NCI E-058-2015-1-JP-04 MATERIALS AND METHODS RELATED TO NSAID CHEMOPREVENTION IN COLORECTAL CANCER JP National Stage 2014-544988 Pending
NCI E-042-2014-0-US-01 Chimeric Antigen Receptors Targeting CD-19 US 62/006,313 Abandoned
NCATS E-234-2012-0-VN-26 PAK Inhibitors For the Treatment of Fragile X Syndrome VN National Stage 1-2014-01801 Pending
NIAID E-148-2009-2-US-03 Use Of Ixolaris, A Tissue Factor Inhibitor, For Inhibiting Angiogenesis US DIV 14/292,232 9272023 Issued PDF